107 related articles for article (PubMed ID: 3666263)
1. Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston).
Cornillie FJ; Puttemans P; Brosens IA
Eur J Obstet Gynecol Reprod Biol; 1987 Sep; 26(1):39-55. PubMed ID: 3666263
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Liang B; Wu L; Xu H; Cheung CW; Fung WY; Wong SW; Wang CC
Reprod Biol Endocrinol; 2018 Apr; 16(1):32. PubMed ID: 29615065
[TBL] [Abstract][Full Text] [Related]
3. Histologic and ultrastructural changes in human endometriotic implants treated with the antiprogesterone steroid ethylnorgestrienone (gestrinone) during 2 months.
Cornillie FJ; Brosens IA; Vasquez G; Riphagen I
Int J Gynecol Pathol; 1986; 5(2):95-109. PubMed ID: 3636281
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of endometriosis with dydrogesterone (Duphaston Depot) in delayed-action preparation form].
Obolensky W; Kamber J
Ther Umsch; 1973 Jul; 30(7):558-61. PubMed ID: 4720335
[No Abstract] [Full Text] [Related]
5. The response of human endometriotic implants to the anti-progesterone steroid R 2323: a histologic and ultrastructural study.
Cornillie FJ; Vasquez G; Brosens I
Pathol Res Pract; 1985 Dec; 180(6):647-55. PubMed ID: 3854475
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery].
Makhmudova GM; Nazhmutdinova DK; Gafarova DKh; Lukmanova IuD
Akush Ginekol (Sofiia); 2003; 42(4):42-6. PubMed ID: 14577368
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis.
Overton CE; Lindsay PC; Johal B; Collins SA; Siddle NC; Shaw RW; Barlow DH
Fertil Steril; 1994 Oct; 62(4):701-7. PubMed ID: 7926076
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of endometriosis in female infertility].
Tumasian KP; Bespoiasnaia VV; Voronovskaia IV
Lik Sprava; 2001; (3):103-5. PubMed ID: 11559992
[TBL] [Abstract][Full Text] [Related]
9. The place of dydrogesterone in the treatment of endometriosis and adenomyosis.
Schweppe KW
Maturitas; 2009 Dec; 65 Suppl 1():S23-7. PubMed ID: 19945806
[TBL] [Abstract][Full Text] [Related]
10. Endocrine dependency of endometriosis: an ultrastructural study.
Schweppe KW; Wynn RM
Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):193-208. PubMed ID: 6734887
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural comparison of endometriotic implants and eutopic endometrium.
Schweppe KW; Wynn RM; Beller FK
Am J Obstet Gynecol; 1984 Apr; 148(7):1024-39. PubMed ID: 6711624
[TBL] [Abstract][Full Text] [Related]
12. Research progress of dydrogesterone in the treatment of endometriosis.
Tang W; Zhu X; Bian L; Zhang B
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():120-125. PubMed ID: 38430648
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal endometriosis: scanning electron microscopy and histology of minimal pelvic endometriotic lesions.
Vasquez G; Cornillie F; Brosens IA
Fertil Steril; 1984 Nov; 42(5):696-703. PubMed ID: 6237941
[TBL] [Abstract][Full Text] [Related]
14. Duphaston depot, a new long-acting progestogen.
Schellen AM
Bull Soc R Belge Gynecol Obstet; 1969; 39(4):327-31. PubMed ID: 5408050
[No Abstract] [Full Text] [Related]
15. Effects of dydrogesterone on the oestrogenized postmenopausal endometrium.
Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
Br J Obstet Gynaecol; 1986 Jan; 93(1):55-62. PubMed ID: 3002419
[TBL] [Abstract][Full Text] [Related]
16. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
[TBL] [Abstract][Full Text] [Related]
17. Histologic features associated with hormonal responsiveness of ectopic endometrium.
Metzger DA; Szpak CA; Haney AF
Fertil Steril; 1993 Jan; 59(1):83-8. PubMed ID: 8419228
[TBL] [Abstract][Full Text] [Related]
18. Dydrogesterone and endometriosis.
Johnston WI
Br J Obstet Gynaecol; 1976 Jan; 83(1):77-80. PubMed ID: 1252380
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
20. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
